News
ANGO
10.34
-1.24%
-0.13
Weekly Report: what happened at ANGO last week (0406-0410)?
Weekly Report · 2d ago
Freedom Broker Initiates Coverage of AngioDynamics (ANGO) with Buy Recommendation
NASDAQ · 04/08 00:05
AngioDynamics Initiated at Buy by Freedom Broker
Dow Jones · 04/07 13:35
AngioDynamics Is Maintained at Buy by Canaccord Genuity
Dow Jones · 04/06 15:19
AngioDynamics Price Target Cut to $16.00/Share From $18.00 by Canaccord Genuity
Dow Jones · 04/06 15:19
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16
Benzinga · 04/06 15:09
AngioDynamics initiated with a Buy at Freedom Broker
TipRanks · 04/06 13:46
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
TipRanks · 04/06 13:15
AngioDynamics price target lowered to $16 from $18 at Canaccord
TipRanks · 04/06 11:01
Canaccord Genuity Remains a Buy on AngioDynamics (ANGO)
TipRanks · 04/06 10:56
Weekly Report: what happened at ANGO last week (0330-0403)?
Weekly Report · 04/06 09:08
AngioDynamics Earnings Call Highlights Med Tech Momentum
TipRanks · 04/06 00:08
AngioDynamics Growing, But With More Noise Than The Street Likes
Seeking Alpha · 04/05 06:06
AngioDynamics (ANGO) Margins Stay Negative In Q2 2026 And Test Bullish Turnaround Hopes
Simply Wall St · 04/03 01:47
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
TipRanks · 04/02 16:29
AngioDynamics signals FY2026 adjusted EBITDA of $10M-$12M while raising net sales guidance to $313.5M-$315.5M
Seeking Alpha · 04/02 14:13
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
TipRanks · 04/02 12:12
AngioDynamics (ANGO) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 04/02 11:15
Earnings Scheduled For April 2, 2026
Benzinga · 04/02 11:11
AngioDynamics Q3 Pro Forma Adj. EBITDA Rises; Lifts FY26 Guidance
NASDAQ · 04/02 11:10
More
Webull provides a variety of real-time ANGO stock news. You can receive the latest news about Angiodynamics through multiple platforms. This information may help you make smarter investment decisions.
About ANGO
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.